BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 10733667)

  • 1. Microvascular arteriovenous shunting is a probable pathogenetic mechanism in erythromelalgia.
    Mork C; Asker CL; Salerud EG; Kvernebo K
    J Invest Dermatol; 2000 Apr; 114(4):643-6. PubMed ID: 10733667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced skin capillary density during attacks of erythromelalgia implies arteriovenous shunting as pathogenetic mechanism.
    Mørk C; Kvernebo K; Asker CL; Salerud EG
    J Invest Dermatol; 2002 Oct; 119(4):949-53. PubMed ID: 12406343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired neurogenic control of skin perfusion in erythromelalgia.
    Mørk C; Kalgaard OM; Kvernebo K
    J Invest Dermatol; 2002 Apr; 118(4):699-703. PubMed ID: 11918719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythromelalgia.
    Ljubojević S; Lipozencić J; Pustisek N
    Acta Dermatovenerol Croat; 2004; 12(2):99-105. PubMed ID: 15075045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prostaglandin E1 analog misoprostol reduces symptoms and microvascular arteriovenous shunting in erythromelalgia-a double-blind, crossover, placebo-compared study.
    Mørk C; Salerud EG; Asker CL; Kvernebo K
    J Invest Dermatol; 2004 Mar; 122(3):587-93. PubMed ID: 15086539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin perfusion in patients with erythromelalgia.
    Littleford RC; Khan F; Belch JJ
    Eur J Clin Invest; 1999 Jul; 29(7):588-93. PubMed ID: 10411664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythromelalgia and myeloproliferative disorders.
    Kurzrock R; Cohen PR
    Arch Intern Med; 1989 Jan; 149(1):105-9. PubMed ID: 2643412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red skin re-read.
    Schechner J
    J Invest Dermatol; 2002 Oct; 119(4):781-2. PubMed ID: 12406320
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythromelalgia in a patient with AIDS.
    Mørk C; Kalgaard OM; Myrvang B; Kvernebo K
    J Eur Acad Dermatol Venereol; 2000 Nov; 14(6):498-500. PubMed ID: 11444274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary erythromelalgia: case report.
    Albuquerque LG; França ER; Kozmhinsky V; Querino MC; Morais AG
    An Bras Dermatol; 2011; 86(1):131-4. PubMed ID: 21437535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms other than shunting are likely contributing to the pathophysiology of erythromelalgia.
    Davis MD; Rooke TW; Sandroni P
    J Invest Dermatol; 2000 Dec; 115(6):1166-7. PubMed ID: 11121163
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythromelalgia: vasculopathy, neuropathy, or both? A prospective study of vascular and neurophysiologic studies in erythromelalgia.
    Davis MD; Sandroni P; Rooke TW; Low PA
    Arch Dermatol; 2003 Oct; 139(10):1337-43. PubMed ID: 14568838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia.
    Michiels JJ; Abels J; Steketee J; van Vliet HH; Vuzevski VD
    Ann Intern Med; 1985 Apr; 102(4):466-71. PubMed ID: 3977194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired skin vasomotor reflexes in patients with erythromelalgia.
    Littleford RC; Khan F; Belch JJ
    Clin Sci (Lond); 1999 May; 96(5):507-12. PubMed ID: 10209083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythromelalgia associated with Clitocybe acromelalga intoxication.
    Nakajima N; Ueda M; Higashi N; Katayama Y
    Clin Toxicol (Phila); 2013 Jun; 51(5):451-4. PubMed ID: 23641936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Erythromelalgia--review of clinical characteristics and therapy].
    Matsumoto H
    No To Shinkei; 1993 Nov; 45(11):1013-7. PubMed ID: 8297661
    [No Abstract]   [Full Text] [Related]  

  • 17. Erythromelalgia: a rare microvascular disease.
    Latessa V
    J Vasc Nurs; 2010 Jun; 28(2):67-71. PubMed ID: 20494297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermoregulatory sweat testing in patients with erythromelalgia.
    Davis MD; Genebriera J; Sandroni P; Fealey RD
    Arch Dermatol; 2006 Dec; 142(12):1583-8. PubMed ID: 17178984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autosomal dominant erythromelalgia.
    Finley WH; Lindsey JR; Fine JD; Dixon GA; Burbank MK
    Am J Med Genet; 1992 Feb; 42(3):310-5. PubMed ID: 1536168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of computer-assisted sensory evaluation in 41 patients with erythromelalgia.
    Genebriera J; Michaels JD; Sandroni P; Davis MD
    Clin Exp Dermatol; 2012 Jun; 37(4):350-4. PubMed ID: 22369570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.